Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 6549-6555, December 15, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waud, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waud, W. R.

Differential Uptake of cis-Diamminedichloroplatinum(II) by Sensitive and Resistant Murine L1210 Leukemia Cells1

William R. Waud

Kettering-Meyer Laboratory, Southern Research Institute, Birmingham, Alabama 35255

The uptake of cis-[14C]dichloro(ethylenediamine)platinum(II) (cis-DEP) is reduced in cis-diamminedichloroplatinum(II) (cis-DDP)-resistant L1210 cells [L1210/DDP (SRI)] in comparison to cis-DDP-sensitive L1210 cells (L1210/0). A difference in uptake is observed as early as 6 min after addition of cis-[14C]DEP and increases to approximately 3-fold after 30 min. This reduction in uptake is reflected in a decrease in the binding of platinum to DNA isolated from cis-DDP-treated cells as measured by atomic absorption spectroscopy and in the quantity of intracellular cis-DEP metabolites as measured by high-performance liquid chromatography. Similar differences in uptake are observed between ascitic L1210/0 and L1210/DDP (SRI) cells in vitro and in vivo, showing that the differences in uptake are not due to an artifact of the culturing process. The differences in cis-DEP uptake between the two cell lines were relatively unchanged during 7 mo in culture; however, both cell lines exhibited altered sensitivities to cis-DEP during extended culturing. No difference was observed in the efflux of cis-DEP by the two cell lines. Similarly, no difference in nonprotein and total sulfhydryl contents was observed between L1210/0 and L1210/DDP (SRI) cells. The difference in uptake (3-fold) of cis-DEP between L1210/0 and L1210/DDP (SRI) cells may not account fully for the observed differences in sensitivity of the two cell lines to cis-DDP (18-fold) and cis-DEP (19-fold). A portion of the resistance may be due to differences in the capacity of the two cell lines to survive in the presence of platinum damage.

1 Supported by Grant CH-273 from the American Cancer Society.

Received 11/ 3/86. Revised 6/29/87. Revised 9/ 4/87. Accepted 9/21/87.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.